课题基金 / 基金详情

Chemogenomic determination of the mechanism of action of a novel drug against multidrug resistant Burkholderia cenocepacia complex

Chemogenomic determination of the mechanism of action of a novel drug against multidrug resistant Burkholderia cenocepacia complex
化学基因组学测定新药抗多重耐药新洋葱伯克霍尔德菌复合体的作用机制
批准号：
367131
负责人：
Hogan Andrew M
金额：
$1.27万
依托单位：
University of Manitoba
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-12-01 至 2017-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=367131&lang=en
关键词：
Bioinformatics Burkholderia Cenocepacia Complex Chemogenomics Confocal Microscopy Cystic Fibrosis Essential Genes Ftsz Gene Regulation Next-Generation Sequencing Novel Antibiotics

项目摘要

项目成果

Hogan Andrew M的其他基金

相关文献

中文摘要
翻译
由于出现抗生素耐药性，药物治疗许多致命传染病的能力正在下降。一些细菌，如新洋葱伯克霍尔德氏菌，对许多目前使用的抗生素表现出天然耐药性。特别是B的感染。ce
英文摘要
The ability of drugs to treat many deadly infectious diseases is decreasing due to emerging antibiotic resistance. Some bacteria, such as Burkholderia cenocepacia show natural resistance to many currently used antibiotics. Specifically, infection by B. ce
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a Genome-Wide Platform to Profile Antibiotic Targets and to Identify Novel Bioactive Scaffolds Effective Against Antibiotic-Resistant Pathogens
  • 批准号：
    404089
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2018
  • 负责人：
    Hogan Andrew M
  • 依托单位：
    University of Manitoba
Developing a Genome-Wide Platform to Profile Antibiotic Targets and to Identify Novel Bioactive Scaffolds Effective Against Antibiotic-Resistant Pathogens
  • 批准号：
    396596
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $10.93万
  • 财政年份：
    2018
  • 负责人：
    Hogan Andrew M
  • 依托单位：
    University of Manitoba